Back to search

United Kingdom· GB-APID-10285811000001100

Bisoprolol 5mg tablets

A bisoprolol product containing bisoprolol, registered in United Kingdom by Relonchem Ltd. The same ATC class is registered in 19 of our 19 countries.

ATC C07AB07

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedBisoprolol 5mg tabletsATCC07AB07REGISTER NO.GB-APID-1028581100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Bisoprolol is registered in 19 of 19 countries.

Countries holding a registration under ATC C07AB07 (bisoprolol), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose

Bisoprolol · ATC C07AB07

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bisoprolol costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.18 in Spain to $0.73 in Switzerland — a ×4.1 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bisoprolol · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.73
  • IT Italy$0.42
  • FR France$0.20
  • ES Spain$0.18
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Bisoprolol
Manufacturer
Relonchem Ltd
Country
United Kingdom (GB)
ATC code
C07AB07
ATC class
Bisoprolol
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5055144200408

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

360 interactions on record for bisoprolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bisoprolol · interactions on record

360 records

  • 11 severe
  • 181 moderate
  • 20 minor
  • 82 info

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe

66 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bisoprolol in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bisoprolol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Bisocor, Bisoprolol
  • Belgium · Bisoprolol Ab, Bisoprolol Eg
  • Bulgaria · Blokbis, Kardoritm
  • Cyprus · Bisoprolol Sapiens, Concor
  • Czechia · Bisocard, Bisoprolol Medreg
  • Germany · Biso Lich, Bisobeta
  • Denmark · Bisoprolol Krka, Bisoprolol Medical Valley
  • Estonia · Bisoprolol Accord, Bisoprolol Vitabalans
  • Spain · Bisoprolol Aurovitas, Bisoprolol Cinfa
  • Finland · Bisoproact, Bisoprolol Accord
  • France · Bisoce, Bisoprolol Accord Healthcare
  • Greece · Blocatens, Concor
  • Croatia · Bisobel, Byol
  • Hungary · Bisoblock, Bisocard
  • Ireland · Bisocor, Bisop
  • Iceland · Bisbetol, Bisoprolol Medical Valley
  • Italy · Bisoprololo Ahcl, Bisoprololo Almus
  • Lithuania · Bisoprolol Fumarate Zentiva, Bisoprolol Vitabalans
  • Luxembourg · Bisoprolol Eg, Bisoprolol Sandoz
  • Latvia · Bisogamma, Bisoprolol Accord
  • Malta · Bisoprolol Ipca
  • Netherlands · Bisoprolol Fumaraat Pch, Bisoprolol Fumaraat Teva
  • Norway · Bisoprolol Sandoz, Bisoprolol Vitabalans
  • Poland · Bibloc, Bicardef
  • Portugal · Bisoprolol, Bisoprolol Aquizent Zentiva
  • Romania · Bisogamma, Bisoprolol Gemax Pharma
  • Sweden · Bisomyl Viatris, Bisoprolol Accord
  • Slovenia · Borez, Byol
  • Slovakia · Bisocard, Bisomerck

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fe6d669b-8332-4604-a801-156a5aa9f5a5
GET /v1/drugs/fe6d669b-8332-4604-a801-156a5aa9f5a5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "10285811000001100",
  "desc": "Bisoprolol 5mg tablets (Relonchem Ltd)",
  "form": "Oral tablet",
  "vpid": "42371511000001109",
  "source": "dmd",
  "vtm_id": "774880006",
  "strength": "5 mg",
  "substance": "Bisoprolol",
  "ingredient": "Bisoprolol fumarate",
  "supplier_code": "10309811000001108"
}

See everything about bisoprolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.